Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Dr. Silvia Calderazzo

Dr. Silvia Calderazzo

Dr. Silvia Calderazzo




+49 6221 42 2387


+49 6221 42 2397


TP 4



Areas of interest

  • Bayesian statistics
  • Bayesian clinical trial design
  • Markov models
  • Dose-response modeling


Education and Background

  • PhD in Statistics, University of Warwick, UK (2017)
  • Master degree in Statistics, University of Padua, Italy (2012)
  • Bachelor degree in Statistics, population and society, University of Padua, Italy (2010)


Selected publications

  • Wiesenfarth, M., & Calderazzo, S. (2019). Quantification of prior impact in terms of prior effective historical and current sample size. Biometrics.
  • Calderazzo, S., Tavel, D., Zurich, M.-G., & Kopp-Schneider, A. (2019). Model-based estimation of Lowest Observed Effect Concentration from replicate experiments to identify potential biomarkers of in vitro neurotoxicity. Archives of toxicology, 1-10.
  • Kopp‐Schneider, A., Calderazzo, S., & Wiesenfarth, M. (2019). Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control. Biometrical Journal.
  • Brenner, H., Calderazzo, S., Seufferlein, T., Ludwig, L., Dikopoulos, N., Mangold, J., ... & Kopp-Schneider, A. (2019). Effect of a Single Aspirin Dose Prior to Fecal Immunochemical Testing on Test Sensitivity for Detecting Advanced Colorectal Neoplasms: A Randomized Clinical Trial. JAMA, 321(17), 1686-1692.
  • Calderazzo, S., Brancaccio, M., & Finkenstädt, B. (2018). Filtering and inference for stochastic oscillators with distributed delays. Bioinformatics, 35(8), 1380-1387.









to top
powered by webEdition CMS